Social & Contextual Impact on Children Undergoing Liver Transplantation
NCT ID: NCT04551742
Last Updated: 2026-01-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
500 participants
OBSERVATIONAL
2020-09-16
2026-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Healthcare providers who take care of children undergoing liver transplant will also be included in the qualitative interviews. The goal of including this group in the study is to determine the health systems barriers and facilitators to social needs screening and intervention.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Factors After Liver Transplantation
NCT05018741
Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection
NCT05117541
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
NCT07312162
Impact of Gender on the Outcome of Liver Transplantation for Hepatocellular Carcinoma
NCT05643833
Changes in Body Composition and Nutritional Status in Patients Undergoing Liver Transplantation
NCT02023190
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children \<18 years of age at the time of transplant
* Undergoing liver transplantation
* Guardian's consent, child assent (in accordance with each institution's IRB policies)
* Consents to enrollment in SPLIT
* Participants who have completed the questionnaire OR
* Medical team member involved in the care of children undergoing liver transplant (e.g., physician, nurse, social worker)
Exclusion Criteria
* Caregiver unwilling or unable to complete the survey
* Child is a ward of the state (e.g., foster care) since present circumstances may not be reflective of child's past or future circumstances
* Non-English, non-Spanish speakers
* Non-US residents
* Declined participation in SPLIT
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of California, San Francisco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sharad Wadhwani, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
University of California, San Francisco
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Children's Hospital Los Angeles
Los Angeles, California, United States
Lucile Packard Children's Hospital
Palo Alto, California, United States
University of California San Francisco
San Francisco, California, United States
Children's Healthcare of Atlanta
Atlanta, Georgia, United States
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, United States
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States
Children's Medical Center Dallas
Dallas, Texas, United States
Seattle Children's Hospital
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
19-29632
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.